Stocks and Investing Stocks and Investing
Tue, April 13, 2021

David Steinberg Upgraded (SUPN) to Strong Buy and Increased Target to $40 on, Apr 13th, 2021


Published on 2024-10-27 16:13:00 - WOPRAI, David Steinberg
  Print publication without navigation


David Steinberg of Jefferies, Upgraded "Supernus Pharmaceuticals, Inc." (SUPN) to Strong Buy and Increased Target from $25 to $40 on, Apr 13th, 2021.

David, nor any peers, have made any analyst calls on SUPN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources